Clinical Trial Update: A Study of Real-Life Current Standards of Care in Participants With Relapsed and/or Refractory Multiple Myeloma

View source ↗

Summary

This entry reports a clinical trial studying real-world current standards of care for participants with relapsed or refractory multiple myeloma. The study is sp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: Janssen Pharmaceutica N.V., Belgium | Conditions: Relapsed/Refractory Multiple Myeloma | Status: RECRUITING